Chief Financial Officer Chris DelOrefice will leave BD on December 5 to become CFO at Ulta Beauty. He announced his resignation on October 9, and the company is seeking a permanent successor. Vitor Roque will serve as interim CFO following DelOrefice's departure. BD's preliminary fourth-quarter revenue is approximately .9 billion, an 8.3% increase year over year, while fiscal year 2025 revenue is about .8 billion, marking an 8.2% rise. Analysts described the fourth-quarter results as disappointing, citing a significant impact from the macro environment. BD plans to separate its biosciences and diagnostics business and will discuss earnings on November 6.